S.P.A.N.C.

This blog is meant to be a place for Sunnybrook Peri-Anesthesia Nurses (Pre-Admission Centre, Same Day Surgery, Post Anesthetic Are Unit and Surgical Short Stay Unit) to stay in communication with each other and to be up-to-date with concerns regarding the Peri-Anesthesia Department. The Purpose of S.P.A.N.C is •To re-implement a unit based council •to identify the unique role of the Peri-anesthesia nurse and to help staff from other areas understand what it is that we do •to create a collegial atmosphere for sharing our professional experiences within the subgroups of Peri-anesthesia •to facilitate open discussion and priority of issues relating to professional practice, education and research that impact on the quality of our work life and thereby affect positive outcomes for our patients and their families.

Friday, August 27, 2010

Nalbuphine (Nubain)

The Acute Pain Service (APS) is revising its standard order sets to reflect the fact that low-dose
nalbuphine has been approved by the Pharmacy & Therapeutics Committee as the first-line treatment for opioid-induced pruritus and as a third-line option for postoperative nausea & vomiting (PONV).
Prescribing is restricted to the APS and Anesthesiology. Nalbuphine is a mixed opioid
agonist-antagonist that, when given in low doses (< 5 mg), can reverse the unwanted effects of other opioids. Because it is acting as an antagonist, lowdose nalbuphine does not require additional monitoring for opioid side effects. Nalbuphine will be used in a dose of 4 mg IV Q4H PRN. Ward nurses are authorized to infuse nalbuphine via minibag over 10-15 minutes; other nurses (ICU’s,ER) can also administer it by direct injection diluted in 2-5 mL of NS over 15 seconds. For IV Drug Monograph, click:
http://sunnynet.ca/data/pharmacy/htdocs/iv_drugs/nalbuphine.pdf
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)